XML 48 R32.htm IDEA: XBRL DOCUMENT v3.25.2

Note 1 - Description of the Business, Basis of Presentation and Summary of Significant Accounting Policies - 10-Q (Tables)

3 Months Ended

12 Months Ended

Jun. 30, 2025

Mar. 31, 2025

Notes Tables

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		June 30,
						2024
		2025				(as revised)
Equity based warrants to purchase common shares			87,531				4,334
Convertible Notes - common shares (1)			-				33,250
Convertible Notes - equity-based warrants to purchase common shares			25,003				25,003
Stock options granted under Company's incentive plan			248,483				216,483
Series A Warrants			1,533,096				-
Representative Warrants			91,985				-
Total potentially dilutive securities			1,986,098				279,070

		March 31,
						2024
		2025				(as revised)
Equity based warrants to purchase common shares			87,531				4,334
Convertible Notes - common shares (1)			-				33,250
Convertible Notes - equity-based warrants to purchase common shares			25,003				25,003
Stock options granted under Company's incentive plan			243,483				100,180
Series A Warrants			1,533,096				-
Representative Warrants			91,985				-
Total potentially dilutive securities			1,981,098				162,767

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

		Three Months Ended June 30, 2024
		Originally Filed				Adjusted for 1-for-20 Reverse Stock Split				Correction				As Revised
Net Loss (in thousands)		$	(2,699	)		$	-			$	-			$	(2,699	)
Loss per share - basic and diluted		$	(0.14	)		$	(2.85	)		$	0.65			$	(2.20	)
Weighted average shares outstanding - basic and diluted			18,902,248				945,382				280,041				1,225,423

		Three Months Ended June 30, 2024
		Originally Filed				Adjusted for 1-for-20 Reverse Stock Split				Correction				As Revised
Equity based warrants to purchase common shares			5,344,569				267,231				(262,897	)			4,334
Convertible Notes - common shares			665,000				33,250				-				33,250
Convertible Notes - equity-based warrants to purchase common shares			500,000				25,003				-				25,003
Stock options granted under Company's incentive plan			4,329,579				216,483				-				216,483
Total potentially dilutive securities			10,839,148				541,967				(262,897	)			279,070

		Twelve Months Ended March 31, 2024
		Originally Filed				Adjusted for 1-for-20 Reverse Stock Split				Correction				As Revised
Net Loss (in thousands)		$	(15,426	)		$	-			$	-			$	(15,426	)
Loss per share - basic and diluted		$	(1.05	)		$	(21.09	)		$	6.27			$	(14.82	)
Weighted average shares outstanding - basic and diluted			14,626,282				731,372				309,348				1,040,720

		Twelve Months Ended March 31, 2024
		Originally Filed				Adjusted f or 1-for-20 Reverse Stock Split				Correction				As Revised
Equity based warrants to purchase common shares			5,744,569				287,231				(282,897	)			4,334
Convertible Notes - common shares			665,000				33,250				-				33,250
Convertible Notes - equity-based warrants to purchase common shares			500,000				25,003				-				25,003
Stock options granted under Company's incentive plan			2,003,600				100,180				-				100,180
Total potentially dilutive securities			8,913,169				445,664				(282,897	)			162,767

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration